Boothbay Fund Management, LLC Karuna Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$93.97 - $143.33 $767,171 - $1.17 Million
8,164 Added 133.18%
14,294 $1.81 Million
Q1 2022

May 16, 2022
BUY
$98.9 - $132.37 $606,257 - $811,428
6,130 New
6,130 $777,000
Q1 2020

May 15, 2020
SELL
$60.41 - $115.92 $181,230 - $347,760
-3,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$11.44 - $123.99 $34,320 - $371,970
3,000 New
3,000 $226,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email